FAECAL CALPROTECTIN TO PREDICT THE RISK OF RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL REMISSION AND ENDOSCOPIC MAYO SCORE 0 OR 1: RESULTS OF THE CALPRODICT-UC STUDY

被引：0
作者：
Buisson, Anthony
Carpentier, Constantin
Minet-Quinard, Regine
Pereira, Bruno
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1732
引用
收藏
页码：S884 / S884
页数：1
相关论文
共 49 条
[31]   Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse [J].
Nakarai, Asuka ;
Kato, Jun ;
Hiraoka, Sakiko ;
Takashima, Shiho ;
Takei, Daisuke ;
Inokuchi, Toshihiro ;
Sugihara, Yuusaku ;
Takahara, Masahiro ;
Harada, Keita ;
Okada, Hiroyuki .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (21) :5079-5087
[32]   Ulcerative Colitis Patients in Clinical Remission Demonstrate Correlations Between Fecal Immunochemical Test Results, Mucosal Healing, and Risk of Relapse [J].
Nakarai, Asuka ;
Kato, Jun ;
Hiraoka, Sakiko ;
Takashima, Shiho ;
Takei, Daisuke ;
Inokuchi, Toshihiro ;
Sugihara, Yuusaku ;
Takahara, Masahiro ;
Harada, Keita ;
Okada, Hiroyuki ;
Yamamoto, Kazuhide .
GASTROENTEROLOGY, 2015, 148 (04) :S194-S194
[33]   Histological remission using a Nancy index of 0 is associated with longer relapse-free survival than histological activity in patients with ulcerative colitis in clinical and endoscopic remission [J].
Pudipeddi, A. ;
Fung, C. ;
Kariyawasam, V. ;
Paramsothy, R. ;
Ghaly, S. ;
Haifer, C. ;
An, Y. ;
Begun, J. ;
Connor, S. ;
Chetwood, J. ;
Paramsothy, S. ;
Leong, R. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 :170-170
[34]   HISTOLOGICAL REMISSION USING A NANCY INDEX OF 0 IS ASSOCIATED WITH LONGER RELAPSE-FREE SURVIVAL THAN HISTOLOGICAL ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION [J].
Pudipeddi, Aviv ;
Fung, Caroline ;
Kariyawasam, Viraj ;
Paramsothy, Ramesh ;
Ghaly, Simon ;
Haifer, Craig ;
An, Yoon ;
Begun, Jakob ;
Connor, Susan ;
Chetwood, John ;
Paramsothy, Sudarshan ;
Leong, Rupert .
GUT, 2022, 71 :A149-A150
[35]   Fecal Calprotectin Levels, C-Reactive Protein Levels, and Partial Mayo Score as Early Predictors of Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Treated With Tofacitinib in a Phase 2 Study [J].
Dubinsky, Marla C. ;
Hudesman, David P. ;
Kulisek, Nicole ;
Salese, Leonardo ;
Paulissen, Jerome ;
Su, Chinyu ;
Magro, Fernando .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 :S474-S475
[36]   Vedolizumab Induces Clinical Response and Remission Across a Range of Baseline Fecal Calprotectin Levels in Patients with Ulcerative Colitis: Results from GEMINI 1 [J].
Wyant, Tim ;
Lewis, James ;
Reinisch, Walter ;
Dassopoulos, Emistocles ;
Ginsburg, Philip ;
Sands, Bruce ;
Feagan, Brian ;
Danese, Silvio ;
Roseth, Arne ;
Rosario, Maria ;
Yang, Huyuan ;
Parikh, Asit ;
Bressler, Brian .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 :S486-S486
[37]   Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study [J].
Shimoyama, Takahiro ;
Yamamoto, Takayuki ;
Umegae, Satoru ;
Matsumoto, Koichi .
BMC GASTROENTEROLOGY, 2018, 18
[38]   Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study [J].
Takahiro Shimoyama ;
Takayuki Yamamoto ;
Satoru Umegae ;
Koichi Matsumoto .
BMC Gastroenterology, 18
[39]   Comparison of Clinical Relapse between Tofacitinib and Filgotinib as Maintenance Therapy in Ulcerative Colitis Patients in Clinical Remission: A Retrospective Propensity Score-Matched Cohort Study [J].
Yagi, S. ;
Fukui, H. ;
Ikenouchi, M. ;
Shiraishi, T. ;
Wakita, M. ;
Takagi, Y. ;
Sato, T. ;
Kawai, M. ;
Kamikozuru, K. ;
Yokoyama, Y. ;
Takagawa, T. ;
Shinzaki, S. .
JOURNAL OF CROHNS & COLITIS, 2025, 19 :i2097-i2097
[40]   Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial [J].
Yarur, Andres J. ;
Chiorean, Michael, V ;
Panes, Julian ;
Jairath, Vipul ;
Zhang, Jinkun ;
Rabbat, Christopher J. ;
Sandborn, William J. ;
Vermeire, Severine ;
Peyrin-Biroulet, Laurent .
JOURNAL OF CROHNS & COLITIS, 2024, 18 (06) :885-894
12345